UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023518
Receipt number R000027083
Scientific Title The utility of ultrasound elastography in obstetrics and gynecology area
Date of disclosure of the study information 2016/08/06
Last modified on 2019/02/16 16:51:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The utility of ultrasound elastography in obstetrics and gynecology area

Acronym

The utility of ultrasound elastography in obstetrics and gynecology area

Scientific Title

The utility of ultrasound elastography in obstetrics and gynecology area

Scientific Title:Acronym

The utility of ultrasound elastography in obstetrics and gynecology area

Region

Japan


Condition

Condition

fetal growth restriction
placenta accreta
pregnancy induced hypertension

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Basically elastography ultrasonically evaluates the deformation ratio of tissues compressed by the same force.The utility of the pattern classification by color mapping has been already established in diseases in superficial organs, such as the mammary gland, prostate gland and thyroid gland areas, where are close to probes. In the liver, which is an underlying organ, the severity of hepatic fibrosis determined by biopsy also actually showed correlation with a color score by elastography, and this is being clinically applied for evaluation of hepatic fibrosis.As mentioned above, elastography is appreciated in various clinical disciplines, and clinical utilities including usage and evaluation scales of elastography are searched and studies in different areas in addition to the above pattern classification procedure by color mapping.
The frequency commonly used for elastography is equivalent to B mode, which is commonly used in clinical practice of obstetrics and whose safety to the human body has been established. Therefore, it is considered that elastography would become an invaluable clinical tool if clinical utility of elastography would be also confirmed in the obstetric area. However, there are still only few study reports about elastography in the obstetric area.
Accordingly, we developed two indices, placental index and HT score, using elastography to evaluate how the placenta hardness correlates with estimated fetus weight in this study. Furthermore, we examined how these indices correlate with histological evaluation based on pathological consideration of placenta after delivery.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Correlation between the Elasticity of the Placental Tissue Evaluated by Ultrasound Elastography and Fetal Growth Restriction (FGR)
Correlation between the Elasticity of the Placental Tissue Evaluated by Ultrasound Elastography and placenta accreta

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Subjects were pregnant women when considered to be after placental formation

Key exclusion criteria

pregnant women with a severe complication

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name TOMOYA HASEGAWA

Organization

Tokyo Medical University

Division name

Department of Obstetrics and Gynecology

Zip code


Address

6-7-1, Nishi-Shinjyuku, Shinjyuku, Tokyo, 160-0023, Japan

TEL

+81-3-3342-6111

Email

ppppq999@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name TOMOYA HASEGAWA

Organization

Tokyo Medical University

Division name

Department of Obstetrics and Gynecology

Zip code


Address

6-7-1, Nishi-Shinjyuku, Shinjyuku, Tokyo, 160-0023, Japan

TEL

+81-3-3342-6111

Homepage URL


Email

ppppq999@gmail.com


Sponsor or person

Institute

Tokyo Medical University

Institute

Department

Personal name



Funding Source

Organization

Tokyo Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 06 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

The average PI was 44.3 in the in utero SGA group, which was significantly higher than that in the normal group 8.8 during pregnancy. There was a significant correlation between the PI and z score for estimated fetal weight (EFW). Moreover, a significant positive correlation was observed between the PI and the z score of birth weight. Pathological ischemia findings of the placenta were identified in 67% of the HT score 3 group, representing 6 of the 9 patients, and in 20% of the HT score 1 group, representing only 3 of the 15 patients.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 02 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 08 Month 06 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2016 Year 08 Month 06 Day

Last modified on

2019 Year 02 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027083